United States· US:81284-831_7c1db393-3664-425f-af20-8d2175fb634e
ANTICHOLIUM
A medicinal product containing physostigmine salicylate, registered in United States by Provepharm Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PHYSOSTIGMINE SALICYLATE
- Manufacturer
- Provepharm Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1181284831055 AMPULE in 1 CARTON (81284-831-05) / 5 mL in 1 AMPULE
- ndc1181284-831-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Physostigmine salicylate in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyAnticholiumDr. Franz Köhler Chemie Gmbh
- CzechiaANTICHOLIUM
- NorwayAnticholiumDr. F. Koehler Chemie
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Austria · Anticholium
- Germany · Anticholium
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9b6efbf1-982f-40c7-8f2f-3743f0022e36 GET /v1/drugs/9b6efbf1-982f-40c7-8f2f-3743f0022e36?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": ".4",
"substance": "PHYSOSTIGMINE SALICYLATE",
"productndc": "81284-831",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE"
}See everything about physostigmine salicylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.